Literature DB >> 25278490

New roles of the multidimensional adipokine: chemerin.

Syeda Sadia Fatima1, Rehana Rehman2, Mukhtiar Baig3, Taseer Ahmed Khan4.   

Abstract

The discovery of several adipokines with diverse activities and their involvement in regulation of various pathophysiological functions of human body has challenged the researchers. In the family of adipokine, chemerin is a novel and unique addition. Ever since the first report on chemerin as a chemo-attractant protein, there are numerous studies showing a multitasking capacity of chemerin in the maintenance of homeostasis, for the activation of natural killer cells, macrophages and dendritic cells in both innate and adaptive immunity. Its diversity ranges from generalized inflammatory cascades to being explicitly involved in the manifestation of arthritis, psoriasis and peritonitis. Its association with certain cancerous tissue may render it as a potential tumor marker. In present review, we aim to consolidate recent data of investigations on chemerin in context to functional characteristics with a special reference to its role as a metabolic signal in inflammation and non-metabolic syndromes.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Chemerin; Inflammation; Metabolic syndrome; Therapeutic role

Mesh:

Substances:

Year:  2014        PMID: 25278490     DOI: 10.1016/j.peptides.2014.09.019

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  25 in total

1.  Chemerin concentrations in infants born small for gestational age: correlations with triglycerides and parameters related to glucose homeostasis.

Authors:  Asier Léniz; Alfredo Fernández-Quintela; Marta Del Hoyo; Ignacio Díez-López; María P Portillo
Journal:  J Physiol Biochem       Date:  2020-06-16       Impact factor: 4.158

2.  Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions.

Authors:  Noha A Ghallab; Olfat G Shaker
Journal:  Clin Oral Investig       Date:  2016-05-10       Impact factor: 3.573

3.  A preliminary candidate approach identifies the combination of chemerin, fetuin-A, and fibroblast growth factors 19 and 21 as a potential biomarker panel of successful aging.

Authors:  Fabian Sanchis-Gomar; Helios Pareja-Galeano; Alejandro Santos-Lozano; Nuria Garatachea; Carmen Fiuza-Luces; Letizia Venturini; Giovanni Ricevuti; Alejandro Lucia; Enzo Emanuele
Journal:  Age (Dordr)       Date:  2015-04-25

4.  Association of chemerin levels and bone mineral density in Chinese obese postmenopausal women.

Authors:  Liang Shi; Chaoming Mao; Xuefeng Wang; Rencong Liu; Lin Li; Xiao Mou; Ping Xu; Hongli Li; Chengcheng Xu; Guoyue Yuan; Bing Wan; Hao Zhang
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

Review 5.  International Union of Basic and Clinical Pharmacology CIII: Chemerin Receptors CMKLR1 (Chemerin1) and GPR1 (Chemerin2) Nomenclature, Pharmacology, and Function.

Authors:  Amanda J Kennedy; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2017-12-26       Impact factor: 25.468

6.  The Potential Role of Chemerin, Lipocalin 2, and Apelin in the Diagnosis and Pathophysiology of Gestational Diabetes Mellitus.

Authors:  Radzisław Mierzyński; Elżbieta Poniedziałek-Czajkowska; Dominik Dłuski; Maciej Kamiński; Agnieszka Mierzyńska; Bożena Leszczyńska-Gorzelak
Journal:  J Diabetes Res       Date:  2021-06-09       Impact factor: 4.011

7.  A neuroendocrine role for chemerin in hypothalamic remodelling and photoperiodic control of energy balance.

Authors:  Gisela Helfer; Alexander W Ross; Lynn M Thomson; Claus D Mayer; Patrick N Stoney; Peter J McCaffery; Peter J Morgan
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

8.  Prenatal and Childhood Growth, Chemerin Concentrations, and Metabolic Health in Adult Life.

Authors:  Johan G Eriksson; Mika Venojärvi; Clive Osmond
Journal:  Int J Endocrinol       Date:  2016-01-24       Impact factor: 3.257

9.  The role of GPR1 signaling in mice corpus luteum.

Authors:  Ya-Li Yang; Li-Rong Ren; Li-Feng Sun; Chen Huang; Tian-Xia Xiao; Bao-Bei Wang; Jie Chen; Brian A Zabel; Peigen Ren; Jian V Zhang
Journal:  J Endocrinol       Date:  2016-05-05       Impact factor: 4.286

10.  Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia.

Authors:  Viktória E Varga; Hajnalka Lőrincz; Noémi Zsíros; Péter Fülöp; Ildikó Seres; György Paragh; József Balla; Mariann Harangi
Journal:  Lipids Health Dis       Date:  2016-10-18       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.